Cargando…
Successful treatment of a Streptococcus pneumoniae-associated haemolytic uraemic syndrome by eculizumab
Haemolytic uraemic syndrome (HUS) is a rare complication of invasive infection by Streptococcus pneumoniae (SP-HUS), especially in adults. Here we report an unusual case of a 53-year-old man presenting SP-HUS with severe multivisceral involvement. After failure of supportive care and plasma exchange...
Autores principales: | Jeantet, Guillaume, Pernin, Vincent, Brunot, Vincent, Roccabianca, Arnaud, Macombe, Anouk, Szwarc, Ilan, Klouche, Kada, Loirat, Chantal, Mourad, Georges, Frémeaux-Bacchi, Véronique, Le Quintrec, Moglie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366139/ https://www.ncbi.nlm.nih.gov/pubmed/30746136 http://dx.doi.org/10.1093/ckj/sfy019 |
Ejemplares similares
-
Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013) -
Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013) -
Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013) -
Treatment of atypical uraemic syndrome in the era of eculizumab
por: Fremeaux-Bacchi, Veronique
Publicado: (2012) -
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017)